Tickers

IP — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 07:54:00.430531 UTC · finished 2026-09-22 08:00:17.050789 UTC

1. Composite Trajectory Verdict

For a capital-intensive packaging company executing a major acquisition and strategic separation, all three statements carry weight, but cash generation and balance-sheet capacity to fund integration, high capex, and the planned spinoff are paramount.

Composite Trajectory: Mixed

Revenue surged 49% to $23.6 billion in FY2025 driven by the DS Smith acquisition (10-K FY2025, Consolidated Statement of Operations), but GAAP earnings from continuing operations collapsed to a $2.8 billion loss from $725 million income a year earlier due to a $2.47 billion goodwill impairment, $958 million accelerated depreciation, and $626 million restructuring charges (10-K FY2025, Consolidated Statement of Operations). Adjusted operating earnings (non-GAAP) fell to -$100 million from $471 million (10-K FY2025, Non-GAAP Financial Measures). Free cash flow (non-GAAP) swung to -$159 million from $757 million as capital expenditures doubled to $1.86 billion (10-K FY2025, Non-GAAP Financial Measures). The balance sheet shows stable leverage (debt/equity ~0.66 both years) but retained earnings dropped $4.5 billion to $4.9 billion and goodwill was impaired by $2.47 billion (10-K FY2025, Consolidated Balance Sheet; MD&A). Thus, scale and revenue improved, while profitability, cash generation, and equity quality deteriorated.

2. Red Flags

  • Goodwill impairment of $2.467 billion in the PS EMEA reporting unit recorded in Q4 2025 (10-K FY2025, Consolidated Statement of Operations)
  • Accelerated depreciation of $958 million associated with mill and strategic actions (10-K FY2025, MD&A – Depreciation and amortization)
  • Restructuring charges of $626 million in 2025 vs. $103 million in 2024 (10-K FY2025, Consolidated Statement of Operations)
  • Free cash flow (non-GAAP) negative $159 million in 2025 vs. positive $757 million in 2024 (10-K FY2025, Non-GAAP Financial Measures)
  • GAAP net loss of $3.5 billion in 2025 vs. net income of $557 million in 2024 (10-K FY2025, Consolidated Statement of Operations)
  • Adjusted operating earnings (non-GAAP) negative $100 million in 2025 vs. positive $471 million in 2024 (10-K FY2025, Non-GAAP Financial Measures)
  • Capital expenditures at 64% of depreciation & amortization in 2025 (vs. 71% in 2024), with D&A inflated by accelerated depreciation (10-K FY2025, Liquidity and Capital Resources)
  • Retained earnings fell from $9.393 billion to $4.885 billion (10-K FY2025, Consolidated Balance Sheet)
  • DS Smith segment operating losses: PS NA -$346 million, PS EMEA -$321 million in 2025 (10-K FY2025, Business Segment Results)
  • Discontinued operations loss of $678 million including $1.07 billion GCF impairment (10-K FY2025, Consolidated Statement of Operations)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

GAAP earnings from continuing operations fell from $313 million (2023) to $725 million (2024) to -$2.838 billion (2025) (10-K FY2025, Consolidated Statement of Operations). The decline was driven by $2.467 billion goodwill impairment, $958 million accelerated depreciation, and $626 million restructuring — all classified as special items. Excluding these, adjusted operating earnings (non-GAAP) dropped from $471 million to -$100 million (10-K FY2025, Non-GAAP Financial Measures). Segment operating profit (which excludes special items) fell in PS NA from $891 million to $572 million (including DS Smith -$346 million) and in PS EMEA from $60 million to -$236 million (including DS Smith -$321 million) (10-K FY2025, Business Segment Results). Legacy PS NA profit improved slightly to ~$918 million; legacy PS EMEA profit rose modestly to ~$85 million, but combined results were overwhelmed by DS Smith losses and one-time charges.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Cash provided by operating activities was flat at $1.698 billion in 2025 vs. $1.678 billion in 2024 (10-K FY2025, Consolidated Statement of Cash Flows). Capital expenditures doubled to $1.857 billion from $921 million (10-K FY2025, Consolidated Statement of Cash Flows), pushing free cash flow (non-GAAP) to -$159 million from $757 million (10-K FY2025, Non-GAAP Financial Measures). Investing cash outflows increased to $1.024 billion from $808 million (10-K FY2025, Consolidated Statement of Cash Flows). Financing outflows were $708 million vs. $775 million, with dividends rising to $977 million from $643 million and no share repurchases under the program in either year (10-K FY2025, Consolidated Statement of Cash Flows). The company funded the capex step-up and higher dividends entirely from operating cash flow and debt issuance ($409 million in 2025 vs. $102 million in 2024).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets grew 66% to $37.964 billion from $22.800 billion, primarily from DS Smith acquisition (10-K FY2025, Consolidated Balance Sheet). Goodwill rose to $5.326 billion from $3.038 billion but includes a $2.47 billion impairment in PS EMEA (10-K FY2025, Consolidated Balance Sheet; MD&A – Critical Accounting Policies). Intangibles jumped to $4.043 billion from $72 million, led by $3.5 billion customer relationships (10-K FY2025, Consolidated Balance Sheet). Total debt increased to $9.831 billion (current $992 million + long-term $8.839 billion) from $5.553 billion (10-K FY2025, Consolidated Balance Sheet). Equity rose to $14.827 billion from $8.173 billion due to $9.7 billion stock issuance for DS Smith (10-K FY2025, Consolidated Statement of Changes in Equity). Debt/equity remained ~0.66. Retained earnings fell $4.5 billion to $4.885 billion. Current ratio declined to 1.28x ($10.1 billion/$7.9 billion) from 1.50x ($6.4 billion/$4.3 billion). Cash held steady at ~$1.15 billion.

6. Data Gaps

  • Quarterly GAAP income statement, cash flow, and balance sheet detail for Q1–Q4 2025 and Q1–Q2 2026 (10-Qs provided are truncated)
  • Quarterly segment sales and operating profit for comparable quarters (YoY quarterly trends)
  • Full-year 2026 results (only H1 2026 available)
  • Pro forma combined company metrics for a full integrated year
  • Detailed breakdown of legacy vs. DS Smith cash flows and capex by segment
  • Post-GCF-sale pro forma leverage and liquidity metrics (sale closed Jan 2026)
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status